Make America Healthy Again: How Pharmaceutical Industry Distrust Has Awakened a Sleeping Giant
10 Things We Learned from the Overreaction to the Coronavirus Pandemic?
The coronavirus pandemic was a global crisis that prompted significant responses from governments, health organizations, and individuals. However, as the dust settles, it’s crucial to examine what we learned from the instances of overreaction during this period. Understanding these lessons can help us prepare better for future emergencies and strike a balance between caution and overreach.
Long Covid Action Project - End A Disease That Was Created In A Lab
Long Covid Action Project - End The Disease That Was Created In A Lab
Dana Carvey's Fauci Impression Is Insane!
I miss Covid. Booster just sounds better. I am introducing a daily COVID shot.
Was Mass Vaccinating in the Public’s Interest or Pfizer’s?
In an earnings report issued Tuesday, the pharmaceutical giant also estimated that sales of its vaccine and anti-viral pill will top $54 billion in 2022, buoying shareholders’ hopes that profits at the company might soar for the second year in a row.
Pfizer CEO Albert Bourla said the company plans to aggressively expand the use of messenger RNA beyond just COVID vaccines, pointing to potential treatments of muscle, the liver and nervous system, despite warnings from many researchers that the use of mRNA technology carries significant risks.
Despite record earnings, Pfizer shares fell 3% yesterday on Wall Street due to lower than expected 2022 sales forecasts for its anti-viral pill, Paxlovid, which it sells at $530 a course in the United States.
Anti-viral pills like ivermectin, which health chiefs have sought to ban or restrict, typically sell for a few dollars when available, with several scientists suggesting the much-maligned pills are more effective than those produced by Pfizer.
Pfizer said its overall sales in 2022 across the company’s product range could reach $102 billion.
“In the early days of the COVID-19 pandemic, we committed to use all of the resources and expertise we had at our disposal to help protect populations globally against this deadly virus, as well as to offer treatments to help avoid the worst outcomes when infections do occur,” Bourla said yesterday. “We put billions of dollars of capital on the line in pursuit of those goals, not knowing whether those investments would ever pay off.”
Reacting to the earnings on Twitter, some commentators remarked on how beneficial mass-vaccination programs had been to the company’s balance sheet.
Bourla also said yesterday that Pfizer’s vaccine for the Omicron variant would not be ready for distribution until March, casting further doubt on calls from health officials and mainstream media outlets to vaccinate people now with shots made for previous variants.
The CEO acknowledged that the eradication of COVID is unlikely to be achieved because of mutations and the virus’ global spread, with some scientists previously warning that new vaccines were contributing to the growth of variants.Was mass vaccinating in the public’s interest or Pfizer’s? https://t.co/ojPAhfiCNE
— Lisa Boothe (@LisaMarieBoothe) February 8, 2022
Ivermectin Adoption By Country Wordwide Map
Strictly regular use of ivermectin as prophylaxis for COVID-19 leads to a 90% reduction in COVID-19 mortality rate, in a dose-response manner: definitive results of a prospective observational study of a strictly controlled 223,128 population from a city-wide program in Southern Brazil
Ivermectin is currently used for about 28% of the world’s population. Countries where COVID-19 mortality is close to zero may not have incentive to adopt treatments. When excluding these countries, ivermectin adoption is about 39%. We excluded countries where the cumulative mortality over the preceding month was less than 1 in 1 million.
Western authorities are presenting our choices as either catch covid eventually (because it is so infectious and now spreading everywhere) or take vaccines every three months (according to the latest guidelines), apparently for the indefinite future. They hide and vigorously “omit” the third alternative: the anti-viral path.
Covid, vaccines, or anti-viral. Which is doing better?
Let’s do a scorecard, of official covid deaths per million population [and current daily cases, total, not per capita] on 26 Dec 2021:
Countries that did not close their borders and went to vaccines as soon as possible:
USA – 2,509 [250k]
UK – 2,161 [120k]
Germany – 1,319 [40k]
France – 1,871 [100k]
Canada – 788 [20k]
Italy – 2,265 [50k]
Russia – 2,077 [25k]
Countries that did not close their borders and, after alarming infection, mostly adopted ivermectin:
India – 342 [8k]
Indonesia – 519 [< 1k]
Japan – 146 [< 1k]
Egypt – 205 [< 1k]
Peru – 6,016 (the country hit hardest, until they used ivermectin) [6k]
Columbia – 2,510 [ 3k]
Venezuela – 188 [< 1k]
Nigeria – 14 [4k]
South Africa – 1,502 [20k]
Countries that closed their borders but have recently opened up:
Australia – 84 [10k]
Western Australia – 0.5 [2 cases yesterday, 7 in last few months]
New Zealand – 10 [70]
Vietnam – 314 [16k]
Taiwan – 36 [14] (borders still closed)
Different policies, different health outcomes. Even a bureaucrat could work it out, eventually.
Meanwhile, Pfizer must be very pleased with themselves — producing the most widely used treatment in history!
Vaccines in the west are too big politically to fail — yet they are. There is only so much you can cover up with propaganda and voodoo statistics.
UPDATE: Ivermectin works as well as vaccines, but does not wane and is without the harmful side effects.
The Study:
Background: Previously, we demonstrated that ivermectin use as prophylaxis for COVID-19 was associated with reductions in COVID-19 infection, hospitalization, and mortality rates, and in the risk of dying from COVID-19, irrespective of regularity and accumulated use of ivermectin, in an observational, prospectively obtained data from a strictly controlled city-wide program in a city in Southern Brazil (Itajaí, SC, Brazil) of of medically-based, optional use of ivermectin as prophylaxis for COVID-19.
In this study, our objective was to explore the data obtained from the program to evaluate whether the level of regularity of ivermectin use impacted in the reductions in these outcomes, aiming to determine if ivermectin showed a progressive dose-, regularity-response in terms of protection from COVID-19 and COVID-19 related outcomes.
Materials and methods: This is a prospective observational study of the program mention above, that used ivermectin at a dose of 0.2mg/kg/day for two consecutive days, every 15 days. We obtained and analyzed the data regarding the accumulated dose of ivermectin use, in addition to age and comorbidities, to analyze the patterns of reduction of COVID-19 infection, hospitalization, and mortality rates, and risk of dying from COVID-19, according to the regularity and amount of ivermectin used in a 5-month period.
Following definitions of regularity, we considered as strictly regular subjects that used at least 180mg of ivermectin (180mg = 30 tablets), and as sporadic users subjects that used 60mg (= 10 tablets) or less during the 5-month period.
Comparisons between subjects that did not use ivermectin and these two levels of regularity of ivermectin use were performed. Analysis of the intermediate levels of ivermectin use are present in the supplement appendix of this study. To analyze hospitalization and mortality rates, we utilized the database of COVID-19 infections of all participants, from Itajaí and outside. To analyze COVID-19 infection rate and risk of dying from COVID-19 we utilized the Itajaí city database.
Propensity score matching (PSM) was employed, followed by multivariate adjusted analysis for residual differences (doubly adjusted analysis).
Results:
Of the 7,345 cases of COVID-19, 3,034 occurred in non-users, 1,627 in sporadic users, and 289 in strict users, while the remaining cases occurred in the intermediate levels of ivermectin use. Strict users were older (p < 0.0001) and non-significant higher prevalence of type 2 diabetes and hypertension.
COVID-19 infection rate was 39% lower among strict users [4.03% infection rate; ( p < 0.0001] than in non-users (6.64% infection rate), and non-significant 11% reduction compared to sporadic users (4.54% infection rate) (n = 1,627 in each group; RR, 0.89; 95%CI 0.76 – 1.03; p = 0.11).
Hospitalization rate was reduced by 100% in strict users, compared to non-users and to sporadic users, both before and after Propensity score matching ( p < 0.0001).
After Propensity score matching, hospitalization rate was 35% lower among sporadic users than non-users (RR, 0.65; 95%CI, 0.44 – 0.70; p = 0.03).
In propensity score matched groups, multivariate-adjusted mortality rate was 90% lower in strict users compared to non-users (p = 0.003) and 79% lower than in sporadic users (p = 0.05), while sporadic users had a 37% reduction in mortality rate compared to non-users (p = 0.043).
Risk of dying from COVID-19 was 86% lower among strict users than non-users (p = 0.006) and marginally significant, 72% lower than sporadic users (p = 0.083), while sporadic users had a 51% reduction compared to non-users (p = 0.001).
Conclusion: Non-use of ivermectin was associated with a 10-times increase in mortality risk and 7-times increased risk of dying from COVID-19, compared to strictly regular use of ivermectin in a prospectively collected, strictly controlled population.
A progressive dose-response pattern was observed between level of ivermectin use and level of protection from COVID-19 related outcomes and consistent across different levels of ivermectin use.
The results of this study clearly demonstrate that prophylactic use of ivermectin must be initiated immediately for people in high risk categories in the United States and worldwide. This includes individuals with one or more co-morbidities and the middle aged/elderly. Our “design-to-fail” government funded clinical trials for early treatment and governmental obstructionism regarding life saving treatments to patients must end now.
The CDC chart below for all deaths since the start of the outbreak clearly shows a jump in cases after 50 years old.
However, as the data for deaths per million per age group is not disclosed, so the age for start of prophylaxis has yet to be determined.
As Omicron has less pathogenicity and slightly different disease profile this too could influence what age prophylaxis treatment should begin. But the data are in, prophylactic use of ivermectin saves lives.
A doctor's decision to inform the patient of the 'off-label' status of the prescription is not relevant to the physician's standard of care for an informed consent case.
The FDA has specifically stated that its procedures and requirements have no effect on the practice of medicine and that the FDA does not prohibit doctors from prescribing drugs in an 'off-label' manner.
The FDA's approval of a drug is immaterial to the effectiveness in the drug's 'off-label' use. In fact, prescribing medication in an 'off-label' manner can constitute the standard of care in many cases.
A doctor's duty is to practice medicine and treat his patient, not inform the patient of the FDA's non-medically related labeling. Therefore, doctors should not be branded with the additional duty of disclosing non-pertinent information, such as the FDA's medically irrelevant distinction, to their patients
*It is estimated that 21% of all prescription drugs are prescribed “off-label.”
For fun, I took the countries that reportedly use Ivermectin country-wide and compared them to the USA, Israel and Sweden. I chose a three month cut-off, although the results were extended further. I did this because I don’t know when some of the countries began ivermectin use.
Can you guess who now has the highest death rates per million? Yeh -
USA
Israel
Sweden
Notes: I included - India, because although not all regions use Ivermectin - although the most populated due. Likewise Africa - which many nations treat with ivermectin prophylactically and these world maps do not break down Africa by Nations (weirdly imperialistic). I did not include Bulgaria, as although they use ivermectin - their death rate numbers are skewed for other reasons not worth delving into.
There are a lot of confounding variables here. Such as natural immunity, vaccination rates of the elderly and those with co-morbidities, as well as seasonality of the virus, vitamin D3/zinc levels and age of population.
But it is still an interesting snap shot as to where much of the world is right now.
Is the Mexican or US Government More Corrupt From Drug Money?
What Is The Big Pharma "Con Job" Theory
When NIAID was refused patents for mRNA "Vaccines"! What Did They Do?
How to Create a Pandemic. The Next Big Idea.
Con Job Definition - noun informal. an act or instance of duping or swindling. an act or instance of lying or talking glibly to convince others or get one's way.
When Dr. Kory testified before the U.S. Senate on December 8, 2020, the message was clear: Ivermectin might well be able to bring the COVID-19 virus to a spectacular halt. Studies were cited that should have convinced experts and laymen alike. Dr. Kory's testimony appeared on YouTube, but—no surprise—it was soon removed by the platform for being "dangerous and misleading". So why did the pharmaceutical industry, the NIH, CDC, NIAID and FDA ignore Dr. Kory?
Everyone knows why, or at least the obvious reason why: a cheap, safe and effective treatment would torpedo Big Pharma's plans to make $$$illions from their rushed-to-market experimental mRNA treatments. The problem, not buried in the fine print, but nonetheless not widely trumpeted at the time: An Emergency Use Authorization for a medical product, such as the EUA sought by Big Pharma for mRNA gene therapy, cannot be granted if there exists a viable and safe treatment for the disease that the experimental product has targeted:
"FDA may authorize unapproved medical products or unapproved uses of approved medical products...when certain criteria are met, including there are no adequate, approved, and available alternatives."
There it is: Ivermectin accepted as a treatment, no EUA for mRNA, no Big Bucks for Big Pharma. As a truly humanitarian gesture, the Senate Committee could have insisted, or at least recommended that an EUA be immediately issued for Ivermectin, but nooooo. A behind-the-scenes eight-hundred-pound gorilla effect?
If one refers back to a 2004 article in the New York Review of Books by Marcia Angell, formerly editor of the prestigious New England Journal of Medicine, (New York Review of Books JULY 15, 2004 ISSUE) we clearly see a few key facts about Big Pharma that provide important background for understanding the present Big Pharma Phiasco. (Bold type emphasis added in the following excerpt.)
"Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself.
"What does the eight-hundred-pound gorilla do? Anything it wants to.
"What’s true of the eight-hundred-pound gorilla is true of the colossus that is the pharmaceutical industry. It is used to doing pretty much what it wants to do. The watershed year was 1980. Before then, it was a good business, but afterward, it was a stupendous one. From 1960 to 1980, prescription drug sales were fairly static as a percent of US gross domestic product, but from 1980 to 2000, they tripled. They now stand at more than $200 billion a year. Of the many events that contributed to the industry’s great and good fortune, none had to do with the quality of the drugs the companies were selling.
"As their profits skyrocketed during the 1980s and 1990s, so did the political power of drug companies. By 1990, the industry had assumed its present contours as a business with unprecedented control over its own fortunes. For example, if it didn’t like something about the FDA, the federal agency that is supposed to regulate the industry, it could change it through direct pressure or through its friends in Congress.
"When I say this is a profitable industry, I mean really profitable. It is difficult to conceive of how awash in money big pharma is. Drug industry expenditures for research and development, while large, were consistently far less than profits. For the top ten companies, they amounted to only 11 percent of sales in 1990, rising slightly to 14 percent in 2000. The biggest single item in the budget is neither R&D nor even profits but something usually called “marketing and administration”—a name that varies slightly from company to company. In 1990, a staggering 36 percent of sales revenues went into this category, and that proportion remained about the same for over a decade. Note that this is two and a half times the expenditures for R&D.
"[But] the industry [now] faces ... problems. It happens that, by chance, some of the top- selling drugs—with combined sales of around $35 billion a year—are scheduled to go off patent within a few years of one another. This drop over the cliff began in 2001, with the expiration of Eli Lilly’s patent on its blockbuster antidepressant Prozac. In the same year, AstraZeneca lost its patent on Prilosec, the original “purple pill” for heartburn, which at its peak brought in a stunning $6 billion a year. Bristol-Myers Squibb lost its best-selling diabetes drug, Glucophage. The unusual cluster of expirations will continue for another couple of years. While it represents a huge loss to the industry as a whole, for some companies it’s a disaster. Schering-Plough’s blockbuster allergy drug, Claritin, brought in fully a third of that company’s revenues before its patent expired in 2002. Claritin is now sold over the counter for much less than its prescription price. So far, the company has been unable to make up for the loss by trying to switch Claritin users to Clarinex—a drug that is virtually identical but has the advantage of still being on patent.
"Even worse is the fact that there are very few drugs in the pipeline ready to take the place of blockbusters going off patent. In fact, that is the biggest problem facing the industry today, and its darkest secret. All the public relations about innovation is meant to obscure precisely this fact. The stream of new drugs has slowed to a trickle, and few of them are innovative in any sense of that word. Instead, the great majority are variations of oldies but goodies—“me- too” drugs.
"Of the seventy-eight drugs approved by the FDA in 2002, only seventeen contained new active ingredients, and only seven of these were classified by the FDA as improvements over older drugs. The other seventy-one drugs approved that year were variations of old drugs or deemed no better than drugs already on the market. In other words, they were me-too drugs. Seven of seventy-eight is not much of a yield. Furthermore, of those seven, not one came from a major US drug company.
"For the first time, in just a few short years, the gigantic pharmaceutical industry is finding itself in serious difficulty. It is facing, as one industry spokesman put it, “a perfect storm.” To be sure, profits are still beyond anything most other industries could hope for, but they have recently fallen, and for some companies they fell a lot. And that is what matters to investors...
"...Nevertheless, the industry keeps promising a bright new day. It bases its reassurances on the notion that the mapping of the human genome and the accompanying burst in genetic research will yield a cornucopia of important new drugs.
"The industry is also being hit with a tidal wave of government investigations and civil and criminal lawsuits. The litany of charges includes illegally overcharging Medicaid and Medicare, paying kickbacks to doctors, engaging in anticompetitive practices, colluding with generic companies to keep generic drugs off the market, illegally promoting drugs for unapproved uses, engaging in misleading direct-to-consumer advertising, and, of course, covering up evidence. Some of the settlements have been huge. TAP Pharmaceuticals, for instance, paid $875 million to settle civil and criminal charges of Medicaid and Medicare fraud in the marketing of its prostate cancer drug, Lupron. All of these efforts could be summed up as increasingly desperate marketing and patent games, activities that always skirted the edge of legality but now are sometimes well on the other side.
"How is the pharmaceutical industry responding to its difficulties? One could hope drug companies would decide to make some changes—trim their prices, or at least make them more equitable, and put more of their money into trying to discover genuinely innovative drugs, instead of just talking about it. But that is not what is happening. Instead, drug companies are doing more of what got them into this situation. They are marketing their me-too drugs even more relentlessly. They are pushing even harder to extend their monopolies on top-selling drugs. And they are pouring more money into lobbying and political campaigns. As for innovation, they are still waiting for Godot.
"This is an industry that in some ways is like the Wizard of Oz—still full of bluster but now being exposed as something far different from its image. Instead of being an engine of innovation, it is a vast marketing machine. Instead of being a free market success story, it lives off government-funded research and monopoly rights. Yet this industry occupies an essential role in the American health care system, and it performs a valuable function, if not in discovering important new drugs at least in developing them and bringing them to market. But big pharma is extravagantly rewarded for its relatively modest functions. We get nowhere near our money’s worth.
"Clearly, the pharmaceutical industry is due for fundamental reform. Reform will have to extend beyond the industry to the agencies and institutions it has co-opted, including the FDA and the medical profession and its teaching centers." [end of excerpt, posted without permission under the "Fair Use" rulings regarding the 1976 Copyright Act for NON-profit academic, research, and general information purposes.]
And clearly, the evidence so diligently exposed by Marcia Angell demonstrates that the pharmaceutical industry—even by the turn of the century—had itself become a systemic chronic disease typical of the capitalist extreme, needing a cure that the patient resists at every turn for there is only one way to cure such a disease. "Reform"? It is a lesson as old as capitalism itself: when an industry grows and grows beyond all reasonable bounds, acquires the means to control its future through big money, bribes, kickbacks, dirty tricks, cheating, murder, crimes against humanity ...and then unforseen circumstances begin to erode the cash-flow.... I need hardly say what the cure is.
All that exposed in 2004! What, then, is the situation today?
Let's go back to the original topic here: already in the early years of the century the pharmaceutical industry was in trouble, looking for "new ways" to keep the big bucks flowing. And now we see Dr. David Martin's patent research evidence, showing that Big Pharma was patenting everything they could dream up, why not? They all surely have big teams of patent lawyers et al., and who knows, if they came to own every conceivable new idea from medical—especially genetic—research, it might all fall into place. "It"?
Patents for mRNA technology, COVID viruses and modifications such as "gain-of-function"—as revealed by Dr. David Martin—were amassed by Big Pharma through the Noughties and Teenies, including patents on the spike protein itself, and eventually arrived to the attempt to patent a general-purpose accepted-by-all remedy for avoiding seasonal flu if not the entire range of such possible viruses. As Marcia Angell notes, vaccines, whether they be classic ones, or the new mRNA techolgy-based injections (technically they are not "vaccines"), remain one of the biggest money-makers for Big Pharma. So we can deduce the mRNA technique was supposed to finally save the industry and restore growth and profitability.
But, disaster!, Tony Fauci and National Institute of Allergy and Infectious Diseases (NIAID) were refused patents for mRNA "vaccines"! Oh dear me! What to do?
Read the Fauci Dossier
Tony and his Big Pharma pals were enraged they couldn’t get a patent on an all-purpose-general-use-mRNA-flu-shot, to be accepted by all good little boys and girls the world over so they wouldn't get the sniffles for Christmas and give a possibly fatal dose to grandma. A "remedy" not only for the sniffles and grandma but for big pharma too—the key to continue to maintain/expand their profits with a new, (patented) revolutionary miracle technique. So the light-bulb pops above Tony’s head as in a Beavis & Butthead classic, “Hey Beavis! Those fart-knockers won't give us a patent? Let’s INTRODUCE the disease we need to get such a vaccine launched. Yeah! he-he-he, huh-huh-huh. Cool!"
My reference here might be thought crude and insulting, but while there are surely many very clever people involved in the Big Pharma Phiasco, scientists, directors, politicians, et al., there appear to be few, if any, who might be thought of as wise. Under the circumstances, the clever be damned.
Now, it seems settled that the research that led to COVID-19 was bioweapon-oriented. But that does not prove it was released (also a near-certainty) intentionally as a bioweapon. That may have happened a little later, as a side-line of the big-money project when Big Pharma chatted with the Pentagon, and it was thought a cool idea to infect some Iranian leaders. Primarily, COVID was released so that Fauci, NIAID & Big Pharma could then demand an EUA and get eventual patents on all such mRNA treatments. But for COVID these people had research indicating they knew the spike protein that was generated by the injection did not remain localized but spread to many organs in the body. What if that should cause "spike protein disease"? It was probably thought that the problem would be minor, and if enough pressure and propaganda be applied, success in "vaccinating the world" could still be achieved, and collateral damage ignored. Unfortunately the spike protein complication resulted in a great many deaths and serious injuries, far, far outnumbering such negative outcomes which in previous incidences of introduction of vaccines, were sufficient to immediately force a withdrawal of the product from further testing.
But the push for world vaccination continues, with such force that one begins, or rather continues to wonder why. Some see a conspiracy to reduce world population. I'd need at least some extensive whistleblower hard data before I'd credit the long list of perpetrators as being that competent, to have planned this thing from the get-go. So far I have to see the whole thing as a Colossal Con Job for Big Bucks turned into a Colossal SNAFU for which the perps are trying very hard to cover their dorsal protuberances. The whole affair is typical of very clever but very unwise participants. Indeed, as a sequel to The Sting, it has been a rip-roaring success, one that you should be embarrassed for having fallen for. As a plan to reduce population, that's strictly sci-fi. If that's the case, the SNAFU is even bigger since the populations dying off most successfully seem to be we Westerners. But Indians, Mexicans, S. Americans... citizens of nations and regions taking the Ivermectin/HCQ route? Apparently they would be the preponderant survivors.
So now that everyone knows we have been mightily deceived, wouldn't there be some better course of action for Big Pharma, the NIH, CDC, NIAID and FDA that could admit error, preserve profit, avoid criminal charges, avoid all sorts of horrible (for Big Pharma) outcomes, and actually benefit society by combining everything we surely now know....
Well, since there is not the least hint from them that they know we know they have been caught out, perhaps we are in store for the next big thing—oh so clever!—whether dreamed up well in advance, or perhaps just recently appearing on the drawing boards: the next medical product that will seal the fate of humanity in partnership with an ever-expanding BIG PHARMA presence and profits-spree. If spike protein has caused problems, why not introduce (after a maximum have been mRNA'd of course) a spike protein cleaner-upper, a scavenger of spike protein residues in the body that will solve all the residual post-vaccination and post-COVID-19 disease problems. Come one, come all! One dose of this miracle oil will Hoover up all harmful COVID residues! Take a third mortgage on your house if necessary! Is such a drug possible? If so, you can bet your bottom dollar on it being even more expensive than Remdesivir, and available only for the privileged, the heavily insured, and third mortgagees.
As Yogi Berra once quipped, "Predictions are hard to make, especially about the future". However, I would certainly be surprised if the Big Pharma Phiasco is not destined for several more entertaining chapters. Be ready. Don't participate ! Stay well !!
Massive Private Equity Companies Like Black Rock & Vanguard Control Our World
Who is Dr. Robert Malone? While working at the Salk Institute in 1988, Dr. Malone discovered important findings about in-vivo and in-vitro RNA transfection. He continued his work on the technology a year later at the biopharma start-up Vical where he conducted additional experiments. According to his bio, “The mRNA, constructs, reagents were developed at the Salk institute and Vical by Dr. Malone.” His research has also included important work on DNA vaccines. In addition to his fundamental work developing mRNA and DNA vaccine technology, Malone is also a medical doctor. According to his bio, Dr. Malone “received his medical training at Northwestern University (MD) and Harvard University (Clinical Research Post Graduate) medical school, and in Pathology at UC Davis."
Few people are as qualified to comment on the course of the COVID pandemic and the mass vaccination campaign as Dr. Malone. In this important interview, he shares his unique and deep insights on matters of critical national and international importance.
What Happens When Biden's Vax Mandates Fail? Lawyers Win Big $
We predict that the failure of the Biden vax mandates will eventually lead to huge legal liability for companies and academic institutions- illegal termination, vaccine damages, etc. This will also be a major financial windfall for independent lawyers.
I predict that the failure of the Biden vax mandates will eventually lead to huge legal liability for companies and academic institutions- illegal termination, vaccine damages, etc. This will also be a major financial windfall for independent lawyers.
— Robert W Malone, MD (@RWMaloneMD) November 13, 2021
"It Raises Serious Constitutional Concerns" - Appeals Court Re-Affirms Stay On Biden Vaccine Mandate
One wouldn't know it by scanning the front pages of say WaPo, NYT or Bloomberg where it wasn't even mentioned, but late on Friday a bad week, month, and year for the scrambling Biden administration - which in addition to the recent disaster in Virginia where a public referendum on "wokeness" saw the public overwhelmingly vote down the Democrats' attempt to subvert social norms, is also facing the worst inflationary inferno since Nixon ended the gold standard - after a U.S. appeals court upheld its decision to put on hold Joe Biden's unconstitutional order for companies with 100 workers or more to demand COVID-19 vaccines, rejecting a challenge by his administration.
A three-member panel of the 5th U.S. Circuit Court of Appeals in New Orleans affirmed its ruling despite the Biden administration's position that halting implementation of the vaccine mandate could lead to dozens or even hundreds of deaths. No Nov 6, the Fifth Circuit granted a temporary stay on enforcement of the federal mandate, one day after the rule was announced. In its reaffirmation Friday, the court said the mandate "exposes [petitioners] to severe financial risk" and "threatens to decimate their workforces (and business prospects)."
"The mandate is staggeringly overbroad," the opinion said adding that the vaccine mandate "raises serious constitutional concerns" and "likely exceeds the federal government’s authority."
"The mandate is a one-size-fits-all sledgehammer that makes hardly any attempt to account for differences in workplaces (and workers)," Circuit Court Judge Kurt Engelhardt wrote for the panel.
5th Circuit affirms OSHA stay applies nationwide. @POTUS can’t mandate vaccines on private companies. #lagov #lalege
— AG Jeff Landry (@AGJeffLandry) November 13, 2021
In its ruling, the Fifth Circuit judges agreed with opponents of vaccine mandates, which have become a deeply controversial topic in the United States (as if the country needed any more of those) - supporters say they are a must to put an end to the nearly two-year coronavirus pandemic, while opponents argue they violate the Constitution and curb individual liberty.
"The public interest is also served by maintaining our constitutional structure and maintaining the liberty of individuals to make intensely personal decisions according to their own convictions - even, or perhaps particularly, when those decisions frustrate government officials," Engelhardt wrote.
At Biden’s orders, the OSHA issued a rule earlier this month requiring U.S. employers with 100 or more workers to ensure their workers are fully vaccinated against COVID-19 or undergoing weekly tests for the virus by Jan 4. Businesses that don’t comply face thousands of dollars in fines.
The rule prompted a slate of legal challenges from at least 27 states as well as business and religious groups who argue the mandate is unconstitutional. Biden and other federal officials argue the mandate is necessary to end the COVID-19 pandemic and fully reopen the economy.
White House officials had no immediate comment on the ruling, which was hailed as a victory by Texas Attorney General Ken Paxton. Texas joined other U.S. states, as well as private employers and religious organizations, in legal challenges to the order.
"Citing Texas's "compelling argument[s]," the 5th Circuit has delayed OSHA's unconstitutional and illegal private-business vaccine mandate. WE WON! Litigation will continue, but this is a massive victory for Texas and for FREEDOM from Biden's tyranny and lawlessness," Paxton wrote.
🚨Citing Texas’s “compelling argument[s],” 5th Circuit has stayed OSHA’s unconstitutional & illegal private-business vaccine mandate. WE WON! Litigation will continue, but this is a massive victory for Texas & FREEDOM from Biden’s tyranny & lawlessness.https://t.co/w7MKyXs73L
— Attorney General Ken Paxton (@KenPaxtonTX) November 13, 2021
Hilarious Get Vaxxed or Face Erectile Dysfunction Video
That Summarizes the Current State of Affairs
Who Are The 'Disinformation' Enemies of Truth?
President Trump Talks About Natural Immunity
Hey Twitter! Why haven't you labeled videos of Biden saying vaccinated people can't spread COVID as "misleading"? Double standard much?
Hey Twitter! Why haven't you labeled videos of Biden saying vaccinated people can't spread COVID as "misleading"? Double standard much? https://t.co/VjGAvY9X0o
— Kelly Bee 🐝 (@ke11ybender) October 13, 2021
“If you get the virus you shouldn’t have to take the vaccine."
FDA & Big Pharma Conflicts of Interest or Corruption?
Some might see people on the FDA as having conflict of interest. The unfortunate thing because for everyone "the sheep" it's business as usual.Some might see this as a conflict of interest. pic.twitter.com/BObmlQu9Js
— ⚡️THOR⚡️ the Deplorable 🇺🇸 (@ThorDeplorable) October 15, 2021
Vanessa Gelman Pfizer's Director of Worldwide Research RUNS Away
Walgreens Employee Accidently Gives Covid Shot To Kids
An Evansville family and their attorney says they were accidentally given full adult doses of the Pfizer coronavirus vaccine instead of flu shots.
Alexandra and Joshua Price say it happened October 4, at the Walgreens on St. Joseph Avenue.
Their family of four includes two adults and two children who are just five and four years old.
The Pfizer vaccine isn’t approved for children that young. They are seeking approval for children ages five to 11, but the dosage would be one-third that of the adult dose. Pfizer has not asked permission to vaccinate children age four or younger.
The family’s attorney, Daniel Tuley, shared with us what he says are the vaccination cards given to the family by Walgreens.
They show children born in 2016 and 2017 were given a Pfizer coronavirus vaccine.
The family says they left the pharmacy thinking they had received their flu shots, but a Walgreens employee later called them and said they had made a mistake.
“Walgreens called me to say there was a mix up, we did not receive the flu shot,” said Alexandra. “And I’m like well what did we get? And he was like we got the Covid19 shot, And instantly I was like, well what does this mean for my kids...?”
The attorney tells us the vaccine cards were then issued since the coronavirus vaccine had been given.
Tuley says the children have been taken to a pediatric cardiologist, and the family was told both are showing signs of heart issues.
“[The cardiologist] said our daughter was having higher blood pressure than she would like,” said Alexandra. “And Lucas, our son was having tachycardia...”
As of Monday, the family says the younger child has been sick with a fever and a cough. Since last week, the family now says the older child has developed a fever.
The family says both children have follow-up appointments with their doctor this week.
We reached out to Walgreens on Thursday, Friday, and Monday.
This is the second instance of Walgreens making this mistake. https://t.co/MJDuFlxg6l https://t.co/rgDOlCAj28
— Libs of Tik Tok (@libsoftiktok) October 10, 2021
Pfizer Uses Human Fetal Tissue For Laboratory Tests
Anthony Fauci of NIH & Rick Bright of HHS 'Conceptualizing A New Avian Flu Virus' - October 29, 2019
Natural Antibodies Are Better Says 3 Pfizer Scientists
Project Veritas released the fourth video of its COVID vaccine investigative series today, which exposes three Pfizer officials saying that antibodies lead to equal if not better protection against the virus compared to the vaccine.
Nick Karl, a scientist who is directly involved in the production of Pfizer’s COVID vaccine, said that natural immunity is more effective than the very own product he works on.
Here are some of the highlights from today’s video:
Nick Karl, Pfizer Scientist: “When somebody is naturally immune -- like they got COVID -- they probably have more antibodies against the virus…When you actually get the virus, you’re going to start producing antibodies against multiple pieces of the virus…So, your antibodies are probably better at that point than the [COVID] vaccination.”
Chris Croce, Pfizer Senior Associate Scientist: “You’re protected for longer” if you have natural COVID antibodies compared to the COVID vaccine.
Croce: “I work for an evil corporation…Our organization is run on COVID money.”
Rahul Khandke, Pfizer Scientist: “If you have [COVID] antibodies built up, you should be able to prove that you have those built up.”
Popular Posts (All Time)
-
Table of Contents Introduction: Stress, Smoking, and Health The Normotim Effect: A New Hope in Stress Management Lithium Ascorbate:...
-
The coronavirus disease (COVID-19) pandemic has been linked to mental health issues related to disease-induced morbidity and mortality and p...
-
A group of virologists in February 2020 published a letter in The Lancet stating they “overwhelmingly conclude that this coronavirus origina...
-
Former Hunter Biden business partner Tony Bobulinski has confirmed that an email published in the New York Post's bombshell exposé is i...
-
SAMPLE LETTER BELOW 🚨🚨🚨 The secret is NOT to refuse the Jabb.... From a lawyer: If you are being forced to Vax in order to keep your job,...
-
The time is now. As most readers of this substack are now well aware, this is not just about COVID. The Constitution hangs in the balance. P...
-
Comment to ACIP meeting of August 30, 2021 submitted by Steve Kirsch - Executive Director of the COVID-19 Early Treatment Fund stk@treatearl...
-
Klaus Schwab's World Economic Forum Government & WHO Lies Tucker & Malone Discuss The World Economic Forum & It's Young ...
-
2 Sources for this story below . . . Justin Bieber reveals he has Ramsay Hunt syndrome Twitter suspended the VaccineTruth2 account Want to ...
-
Crimes Against Humanity - The PCR Test Fraud and COVID-19 will be the Case of the Century Reiner Fuellmich - Update on Court Case & P...